Tecentriq and Stability in Light
This letter responds to your request for information on Tecentriq® (atezolizumab) and stability in light.
Last updated October 11, 2024
Summary
- Tecentriq vials for intravenous (IV) and subcutanous (SC) administration should be protected from light and stored in the outer carton.
- Diluted IV solutions of Tecentriq in an infusion bag
- should be protected from light, and are physically and chemically stable during a 30-day storage period in a fridge (2-8oC), and
- are physically and chemically stable for 24 hours at 30oC, in ambient room light conditions.
- Prepared Tecentriq injections for SC administration
- should be protected from light during a 30-day storage period in a fridge (2-8oC), and are physically and chemically stable for 8 hours at 30oC, in ambient room light conditions.
Recommendations for Tecentriq light storage conditions
Consult your local label for information on Tecentriq storage conditions. Table 1 describes the light storage conditions for Tecentriq IV and SC formulations.[1,2]
Table 1. Light storage conditions for Tecentriq IV and SC formulations
References
- Roche Internal Technical Report (Accessed on October 2024).
- Roche Internal Regulatory Document (Accessed October 2024).
